Health ❯ Public Health ❯ Infectious Diseases ❯ Influenza

Flu Vaccination

FDA Approves Moderna’s mFlusiva for Adults 50 and Older

The authorization brings the first U.S.‑licensed mRNA seasonal flu vaccine but its public rollout is uncertain because the CDC advisory panel cannot meet to set formal recommendations.

14 ARTICLES

3mo ago

FDA Advisers Unanimously Back Moderna’s mRNA Flu Vaccine

19 ARTICLES

8mo ago

Virginia Reports First Child Flu Death During Brief National Lull in Severe H3N2 Season

24 ARTICLES

9mo ago

LA and Riverside Counties Report First Flu Deaths of 2025–26 Season

Flu Vaccination

FDA Approves Moderna’s mFlusiva for Adults 50 and Older

FDA Advisers Unanimously Back Moderna’s mRNA Flu Vaccine

Virginia Reports First Child Flu Death During Brief National Lull in Severe H3N2 Season

U.S. Flu Metrics Dip Slightly, but H3N2 Wave Keeps Pressure on Hospitals

Flu Hospital Numbers Rebound in England as NHS Warns Winter Pressures Intensify

Flu Surges to 25-Year High as H3N2 ‘Subclade K’ Drives U.S. Wave

Flu Visits Hit Record Levels as Drifted H3N2 Variant Drives Early U.S. Surge

Flu Surge Accelerates Nationwide as New York Sets Weekly Hospitalization Record

U.S. Pediatric Flu Deaths Rise to Nine as H3N2 Surge Strains Hospitals

Flu Hospitalizations Double as H3N2 Subclade K Drives Early U.S. Surge

New York Sets Record for Weekly Flu Cases as Hospitalizations Climb

Flu Season Accelerates as H3N2 Subclade K Becomes Dominant in the U.S.

Detroit Medical Center Tightens Visitor Rules as Flu Cases Climb

New York Flu Surge Accelerates as H3N2 Variant Gains Ground

LA and Riverside Counties Report First Flu Deaths of 2025–26 Season

Never miss stories about

Flu Vaccination